NCT00990704 - Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Secondary HyperparathyroidismHemodialysis

Interventions

DRUG

paricalcitol

Intravenous administration 3 times a week immediately before completion of dialysis

DRUG

maxacalcitol

Intravenous administration 3 times a week immediately before completion of dialysis

Trial Locations (14)

Site Ref # / Investigator 53794, Anjo

Site Ref # / Investigator 53787, Chiba

Site Ref # / Investigator 53786, Kumagaya

Site Ref # / Investigator 53792, Matsumoto

Site Ref # / Investigator 53784, Mito

Site Ref # / Investigator 53796, Nagasaki

Site Ref # / Investigator 53795, Osaka

Site Ref # / Investigator 21561, Sapporo

Site Ref # / Investigator 53789, Tokyo

Site Ref # / Investigator 53790, Tokyo

Site Ref # / Investigator 53793, Toyohashi

Site Ref # / Investigator 53785, Tsuchiura

Site Ref # / Investigator 53788, Yachiyo

Site Ref # / Investigator 53791, Yokosuka